Sinopharm And Gansu Government Sign Strategic Cooperation Agreement
This article was originally published in PharmAsia News
Executive SummarySinopharm and the Gansu Provincial Party Committee Secretary recently signed a strategic cooperation framework agreement, which will increase investment in Gansu's drug industry. Under the agreement Sinopharm will cooperate in the construction of a traditional Chinese medicine production and processing center, speed up construction of a drug logistics and distribution network, participate in the reorganization of Gansu drug companies, and aid in pharmaceutical industry development planning. Secretary Lu Hao said Gansu province is not only rich in Chinese herbal medicine resources, but also possesses industrial advantages that create potential for pharmaceutical industry development. (Click Here For More - Chinese Language
You may also be interested in...
Phase III data earns a breakthrough therapy designation for Resverlogix’ apabetalone; previous companies to follow that strategy swiftly advance to NDA submission, as seen with Novartis’ capmatinib and Seattle Genetics’ tucatinib.
Pink Sheet analysis finds that evidence from early-stage trials supports most BTD requests, but about three in 10 designations are granted on the basis of pivotal-stage data.
Four House hearings show how far away even many Democrats are from supporting a single payer system in the US.